Aptiom FDA Approved Drugs
APTIOM [Eslicarbazepine AcetateC17H16N2O3]
200mg (oral tablet)
400mg (oral tablet)
600mg (oral tablet)
800mg (oral tablet)
Sunovion Pharms IncNov 8, 2013
- Approved indications: aptiom (eslicarbazepine acetate) is indicated as adjunctive treatment of partial-onset seizures and approved in patients with epilepsy. patent claims: in a method of treating a subject afflicted with epilepsy.
- Method of treating epilepsy.
- Monotherapy or adjunctive therapy for treatment of partial-onset seizures and approved in patients with epilepsy.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.